Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FDPS | P14324 | 1/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | KCNA5 | P22460 | 2/20 | 0.34 |
| ▸ | CA12 | O43570 | 3/20 | 0.33 |
| ▸ | CA2 | P00918 | 3/20 | 0.33 |
| ▸ | CA9 | Q16790 | 3/20 | 0.33 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28697019 | 0.97 | FDPS (0.42) | FDPSTSHRKCNA5CA12CA2 | |
| Dimethylamine SCHEMBL7551177 | 0.92 | FDPS (0.39) | FDPSTSHRKCNA5 | |
| SCHEMBL2058570 | 0.89 | FDPS (0.38) | FDPSTSHRKCNA5TDP1 | |
| SCHEMBL7775290 | 0.89 | FDPS (0.38) | FDPSTSHRKCNA5CA12CA2 | |
| SCHEMBL1285192 | 0.88 | — | — | |
| SCHEMBL24857733 | 0.87 | DNM1 (0.39) | FDPSTSHRCA12CA2CA9 | |
| SCHEMBL16343266 | 0.87 | FDPS (0.37) | FDPSKCNA5 | |
| SCHEMBL2057863 | 0.86 | — | — | |
| SCHEMBL2058571 | 0.84 | KCNA5 (0.45) | FDPSTSHRKCNA5HSD17B10TDP1 | |
| SCHEMBL331155 | 0.82 | MMP1 (0.38) | FDPSTSHRCA12CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1004 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025131704-A1 | WATER-BASED HYDRAULIC FLUIDS | CLARIANT INTERNATIONAL LTD (CH) | 2025-06-26 | — | — | WO | claimed |
| US-20240352293-A1 | Solvent-Based Polyurethane Adhesive Composition for Bonding Flexible Packaging Material | HENKEL AG & CO KGAA (DE) | 2024-10-24 | — | — | US | claimed |
| CN-107619728-B | Oxide-removing cleaning composition and cleaning method using same | 三星显示有限公司 | 2024-07-16 | — | — | CN | claimed |
| US-20240207158-A1 | DYEING COMPOSITION COMPRISING DIRECT DYES | KAO CORPORATION (JP) | 2024-06-27 | — | — | US | claimed |
| US-20240197606-A1 | COSMETIC PRODUCT FOR DYEING KERATIN FIBERS | KAO CORPORATION (JP) | 2024-06-20 | — | — | US | claimed |
| EP-4221666-B1 | HAIR DYEING COMPOSITION COMPRISING BLUE DYES | KAO CORP (JP) | 2024-06-12 | — | — | EP | claimed |
| CN-118164447-A | Method for preparing intercalated zirconium phosphate by using solvent extraction system | 中南民族大学 | 2024-06-11 | — | — | CN | claimed |
| CN-118164448-A | Circulation process for preparing intercalated zirconium phosphate based on solvent extraction system | 中南民族大学 | 2024-06-11 | — | — | CN | claimed |
| EP-4356737-A2 | BIOCIDE | Purgos ApS (DK) | 2024-04-24 | — | — | EP | claimed |
| CN-117777431-A | Hydrophobic functionalized steel bar rust inhibitor, preparation method and application thereof | 江苏省建筑科学研究院有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-101398639-A | Composition for stripping and stripping method | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-04-01 | — | — | CN | claimed |
| WO-2005074946-A1 | STABLE AND ACTIVE COMPLEXES OF ADENOSINE AND ADENOSINE PHOSPHATES WITH AMINOALCOHOLS FOR THE TREATMENT OF PULMONARY ARTERY HYPERTENSION, CARDIAC FAILURE AND OTHER DISEASES | ADENOBIO N.V. (NL) | 2005-08-18 | — | — | WO | claimed |
| US-20050176675-A1 | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases | ADENOBIO N.V. (NL) | 2005-08-11 | — | — | US | claimed |
| US-5185037-A | Esterification with higher alcohol; treating with alkali | IDEMITSU KOSAN COMPANY LIMITED (JP) | 1993-02-09 | — | — | US | claimed |
| EP-0122151-B1 | PRODUCTION OF PRIMARY OR SECONDARY ALCOHOL DERIVATIVES OF PHOSPHOLIPIDS BY THE ENZYMATIC TECHNIQUE | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1989-02-15 | — | — | EP | claimed |
| US-4783402-A | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1988-11-08 | — | — | US | claimed |
| EP-0256896-A2 | Cerium alcanolatoamines | RHONE-POULENC CHIMIE (FR) | 1988-02-24 | — | — | EP | claimed |
| US-4696975-A | VINYL POLYMER AND POLYEPOXY COMPOUND; PAINTS, ADHESIVES, SEALERS | DAINIPPON INK AND CHEMICALS, INC. (JP) | 1987-09-29 | — | — | US | claimed |
| EP-0122151-A2 | Production of primary or secondary alcohol derivatives of phospholipids by the enzymatic technique | MEITO SANGYO KABUSHIKI KAISHA (JP) | 1984-10-17 | — | — | EP | claimed |
| US-4192820-A | Preparation of 3-methyl-2-buten-1-al | BASF AKTIENGESELLSCHAFT (DE) | 1980-03-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050176675-A1 | Stable and active complexes of adenosine and adenosine phosphates with aminoalcohols for the treatment of pulmonary artery hypertension, cardiac failure and other diseases | ADK, ADORA3, ADORA1 | FDPS 922/4885TSHR 4454/4885KCNA5 1641/4885 |
| US-20240197606-A1 | COSMETIC PRODUCT FOR DYEING KERATIN FIBERS | KRT18, H1-4, H1-0 | FDPS 3930/4885TSHR 2012/4885KCNA5 615/4885 |
| US-20240207158-A1 | DYEING COMPOSITION COMPRISING DIRECT DYES | KRT18, IK, H1-3 | FDPS 4556/4885TSHR 2989/4885KCNA5 306/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.